BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 19051296)

  • 21. Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detection.
    Urakami S; Shiina H; Enokida H; Kawakami T; Kawamoto K; Hirata H; Tanaka Y; Kikuno N; Nakagawa M; Igawa M; Dahiya R
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2109-16. PubMed ID: 16609023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
    Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
    Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. beta-Catenin/Wnt signaling regulates expression of the membrane type 3 matrix metalloproteinase in gastric cancer.
    Lowy AM; Clements WM; Bishop J; Kong L; Bonney T; Sisco K; Aronow B; Fenoglio-Preiser C; Groden J
    Cancer Res; 2006 May; 66(9):4734-41. PubMed ID: 16651426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Epigenetic inactivation of the WNT antagonist SFRP1 in breast cancer].
    Dahl E; Veeck J; An H; Wiesmann F; Klopocki E; Sauter G; Kristiansen G; Hartmann A; Knüchel R
    Verh Dtsch Ges Pathol; 2005; 89():169-77. PubMed ID: 18035687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequent epigenetic inactivation of SFRP genes and constitutive activation of Wnt signaling in gastric cancer.
    Nojima M; Suzuki H; Toyota M; Watanabe Y; Maruyama R; Sasaki S; Sasaki Y; Mita H; Nishikawa N; Yamaguchi K; Hirata K; Itoh F; Tokino T; Mori M; Imai K; Shinomura Y
    Oncogene; 2007 Jul; 26(32):4699-713. PubMed ID: 17297461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methylation of the calcium channel-related gene, CACNA2D3, is frequent and a poor prognostic factor in gastric cancer.
    Wanajo A; Sasaki A; Nagasaki H; Shimada S; Otsubo T; Owaki S; Shimizu Y; Eishi Y; Kojima K; Nakajima Y; Kawano T; Yuasa Y; Akiyama Y
    Gastroenterology; 2008 Aug; 135(2):580-90. PubMed ID: 18588891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Promoter methylation of the secreted frizzled-related protein 1 gene SFRP1 is frequent in hepatocellular carcinoma.
    Shih YL; Shyu RY; Hsieh CB; Lai HC; Liu KY; Chu TY; Lin YW
    Cancer; 2006 Aug; 107(3):579-90. PubMed ID: 16795071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aberrant methylation of the CHFR gene in digestive tract cancer.
    Morioka Y; Hibi K; Sakai M; Koike M; Fujiwara M; Kodera Y; Ito K; Nakao A
    Anticancer Res; 2006; 26(3A):1791-5. PubMed ID: 16827108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclooxygenase-2 inhibitors down-regulate osteopontin and Nr4A2-new therapeutic targets for colorectal cancers.
    Zagani R; Hamzaoui N; Cacheux W; de Reyniès A; Terris B; Chaussade S; Romagnolo B; Perret C; Lamarque D
    Gastroenterology; 2009 Oct; 137(4):1358-66.e1-3. PubMed ID: 19549529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypermethylation of APC promoter 1A is associated with moderate activation of Wnt signalling pathway in a subset of colorectal serrated adenomas.
    Fu X; Li J; Li K; Tian X; Zhang Y
    Histopathology; 2009 Nov; 55(5):554-63. PubMed ID: 19912361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of gastric cancer cell growth by targeting the beta-catenin/T-cell factor pathway.
    Dvory-Sobol H; Sagiv E; Liberman E; Kazanov D; Arber N
    Cancer; 2007 Jan; 109(2):188-97. PubMed ID: 17149756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
    Shan BE; Wang MX; Li RQ
    Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SFRP1 and SFRP2 suppress the transformation and invasion abilities of cervical cancer cells through Wnt signal pathway.
    Chung MT; Lai HC; Sytwu HK; Yan MD; Shih YL; Chang CC; Yu MH; Liu HS; Chu DW; Lin YW
    Gynecol Oncol; 2009 Mar; 112(3):646-53. PubMed ID: 19095296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methylation of Wnt antagonist genes: a useful prognostic marker for myelodysplastic syndrome.
    Wang H; Fan R; Wang XQ; Wu DP; Lin GW; Xu Y; Li WY
    Ann Hematol; 2013 Jan; 92(2):199-209. PubMed ID: 23093371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of gastric cancer invasion and metastasis by PLA2G2A, a novel beta-catenin/TCF target gene.
    Ganesan K; Ivanova T; Wu Y; Rajasegaran V; Wu J; Lee MH; Yu K; Rha SY; Chung HC; Ylstra B; Meijer G; Lian KO; Grabsch H; Tan P
    Cancer Res; 2008 Jun; 68(11):4277-86. PubMed ID: 18519687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hydrocamptothecin promotes the mRNA expression of Wnt signaling inhibitor DKK-1].
    LA L; Ban W; Rao JJ; Wu SG
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Apr; 28(4):623-6. PubMed ID: 18495606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequent aberrant methylation of the CDH4 gene promoter in human colorectal and gastric cancer.
    Miotto E; Sabbioni S; Veronese A; Calin GA; Gullini S; Liboni A; Gramantieri L; Bolondi L; Ferrazzi E; Gafà R; Lanza G; Negrini M
    Cancer Res; 2004 Nov; 64(22):8156-9. PubMed ID: 15548679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional Loss of the gamma-catenin gene through epigenetic and genetic pathways in human prostate cancer.
    Shiina H; Breault JE; Basset WW; Enokida H; Urakami S; Li LC; Okino ST; Deguchi M; Kaneuchi M; Terashima M; Yoneda T; Shigeno K; Carroll PR; Igawa M; Dahiya R
    Cancer Res; 2005 Mar; 65(6):2130-8. PubMed ID: 15781623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Menin promotes the Wnt signaling pathway in pancreatic endocrine cells.
    Chen G; A J; Wang M; Farley S; Lee LY; Lee LC; Sawicki MP
    Mol Cancer Res; 2008 Dec; 6(12):1894-907. PubMed ID: 19074834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetic silencing of cyclooxygenase-2 affects clinical outcome in gastric cancer.
    de Maat MF; van de Velde CJ; Umetani N; de Heer P; Putter H; van Hoesel AQ; Meijer GA; van Grieken NC; Kuppen PJ; Bilchik AJ; Tollenaar RA; Hoon DS
    J Clin Oncol; 2007 Nov; 25(31):4887-94. PubMed ID: 17971584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.